Anorexie en gewichtsverlies
- Beleid en behandeling
Ontstaanswijze bij kanker, hartfalen, COPD of ALS
- Effect voedingsinterventies op gewicht en kwaliteit van leven
Abu-Rustum NR (1997)
Abu-Rustum NR, Barakat RR, Venkatraman E et al. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynec Oncol 1997; 64: 493-495.
Aguilaniui B (1992)
Aguilaniui B, Goldstein-Shapses S, Pajon A et al. Muscle protein degradation in severely malnourished patients with chronic obstructive pulmonary disease subject to short-term total parenteral nutrition. JPN 1992; 16: 248-254.
Akrabawi SS (1996)
Akrabawi SS, Morbarhan S, Stolz RR et al. Gastric emptying, pulmonary function, gas exchange and respiratory quotient after feeding a moderate versus high fat enteral formula in chronic obstructive pulmonary disease patients. Nutrition 1996; 12: 260-265.
Andrew IM (2009)
Andrew IM, Waterfield K, Hildreth AJ et al. Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome. Palliat Med 2009; 23: 680-688.
Anker MS (2010)
Anker MS, Von Haehling S, Springer J et al. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J Cardiol 2013; 162: 73-76.
Anker SD (2006)
Anker SD, John M, Pedersen PU et al. ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr 2006; 25: 311-318.
Anker SD (2009)
Anker SD, Leviano A, Filippatos G et al. ESPEN guidelines on parenteral nutrition: on cardiology and pulmonology. Clin Nutr 2009; 28: 455-460.
Anker SD (2004)
Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med 2004; 36: 518-529.
Anker MS (2013)
Anker MS, Von Haehling S, Springer J et al. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J Cardiol 2013; 162: 73-76.
Arends J (2006)
Arends J, Bodoky G, Bozzetti F et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clinical Nutrition 2006; 25: 245-259.
Arutiunov GP (2003)
Arutiunov GP, Kostiukevich OI, Rylova NV et al. Effect of enteral feeding on exercise tolerance and clinical picture in patients with NYHA class III-IV chronic heart failure. Kardiologiia 2003; 43: 52-55.
August DA (2009)
August DA, Huhmann MB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parent Enteral Nutr 2009; 33: 472-500.
August DA (1991)
August DA, Thorn D, Fisher RL et al. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr 1991; 15: 323-327.
Bachmann P (2003)
Bachmann P, Marti-Massoud C, Blanc-Vincent MP et al. Summary version of the standards, options and recommendations for palliative or terminal nutrition in adults with progressive cancer (2003). Br J Cancer 2003; 89 (Suppl. 1): S107-110.
Baldwin C (2012)
Baldwin C, Spiro A, Ahern R et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2012; 104: 371-385.
Baldwin C (2011)
Baldwin C, Spiro A, McGough C et al. Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Human Nutr Dietetics 2011; 24: 431-440 (2011).
Baldwin C (2008)
Baldwin C, Spiro A, McGough C, et al. The NUT-study: the effect of dietetic and oral nutritional interventions on survival and quality of life in patients with weight loss undergoing palliative chemotherapy for gastrointestinal or lung malignancy, a randomised controlled trial. Proc Nutr Soc 2008; 67(OCE3); E316.
Baracos VE (2006)
Baracos VE. Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 2006; 26: 435-61.
Batterham MJ (2001)
Batterham MJ, Garsia R. A comparison of megestrol acetate, nandrolonedecanoate and dietary counseling for HIV associated weight loss. International Journal of Andrology 2001; 24: 232-240.
Berry JK (2004)
Berry JK, Baum C. Reversal of chronic obstructive pulmonary disease-associated weight loss: are there pharmacological treatment options? Drugs. 2004; 64: 1041-1052.
Blum D (2011)
Blum D, Omlin A, Baracos VE et al. Cancer cachexia: a systematic review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol 2011; 80: 114-144.
Blum D (2010)
Blum D, Omlin A, Fearon K et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Supp Care Cancer 2010; 18: 273-279.
Borbos-Silva MCG (2008)
Borbos-Silva MCG. Subjective and objective nutritional assessment parameters: what do they really assess? Curr Opin Clin Nutr Metab Care 11:248–254.
Bosaeus I (2008)
Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Supportive Care in Cancer 2008; 16: 447-451.
Bossola M (2011)
Bossola M, Pacelli F, Rosa F et al. Does nutrition support stimulate tumor growth in humans? NutrClinParct 2011; 26: 174-180.
Boyd KJ (1994)
Boyd KJ, Beeken L. Tube feeding in palliative care: benefits and problems. Palliative Medicine 1994; 8: 156-158.
Bozzetti F (2002)
Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D, et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002; 21: 281–8.
Bozzetti F (2003)
Bozzetti F. Home total parenteral nutrition in incurable cancer patients: a therapy, a basic human care or something in between? Clinical Nutrition 2003; 22: 109-111.
Bozzetti F (2009)
Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. Journal of Parenteral and Enteral Nutrition 2009; 33: 361-367.
Bozzetti F (2009)
Bozzetti F, Mori V. Nutritional support and tumor growth in humans: a narrative review of the literature. Clinical Nutrition 2009; 28: 226-230.
Bozzetti F (2013)
Bozzetti F. Nutritional support of the oncology patient. Clin Rev Oncol/Hematol 2013; 87: 173-200.
Brard L (2006)
Brard L, Weitzen S, Strubel-Lagan SL et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynec Oncol 2006; 103: 176-180.
Broekhuizen R (2005)
Broekhuizen R, Creutzberg EC, Weling-Scheepers CA et al. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease. BJN 2005; 93: 965-971.
Brown JK (2002)
Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncology Nursing Forum 2002; 29: 517-532.
Brown SE (1985)
Brown SE, Nagendran RC, McHugh JW et al. Effects of a large carbohydrate load on walking performance in chronic air-flow obstruction. Am Rev Respir Dis 1985; 132: 960-962.
Bruera E (2000)
Bruera E, Belzile M, Neumann C et al. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. Journal of Pain and Symptom Management 2000; 19: 427-435.
Bruera E (1996)
Bruera E, Seifert L, Watanabe S et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. Journal of Pain and Symptom Management 1996; 11: 147-153.
Canada T (2002)
Canada T. Clinical dilemma in cancer: is tumor growth during nutrition support significant? Nutrition in Clinical Practice 2002; 17: 246-248.
Caro MM (2007)
Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clinical Nutrition 2007; 26: 26: 289-301 (2007a).
Caro MM (2007)
Caro MM, Laviano A, Pichard C. Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutrition Met Care 2007; 10: 480-487 (2007b).
Chermesh I (2011)
Chermesh I, Mashiach T, Amit A et al. Home parenteral nutrition for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol 2011; 28: 83-88.
Chio A (1999)
Chio A, Finocchiaro E, Meineri P et al. Safety and factors related to survival after percutaneous gastrostomy in ALS. Neurology 1999; 53: 1123-1125.
Collins PF (2013)
Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology 2013; 18: 616-629.
Collins PF (2012)
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:1385-95.
Colomer R (2007)
Colomer R, Moreno-Nogueira JM, Garcia-Luna PP et al. N-3 Fatty acids, cancer and cachexia : a systematic review of the literature. Br J Nutr 2007;97:823-831.
Cozzaglio L (1997)
Cozzaglio L, Balzola F, Cosentino F et al. Outcome of cancer patients receiving home parenteral nutrition. Italian Society of Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 1997; 21: 339-342.
Creutzberg EC (2003)
Creutzberg EC, Wouters EFM, Mostert R et al. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003; 19: 120-127.
Czaplinski A (2006)
Czaplinski A, Yen AA, Simpson EP et al. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Arch Neur 2006; 63: 1139-1143.
Davis MP (2004)
Davis MP, Dreicer R, Walsh D et al. Appetite and cancer-associated anorexia: a review. J Clin Oncol 2004; 22: 1510-1517. [link]
Davis MP (2006)
Davis MP, Walsh D, Lagman R et al. Early satiety in cancer patients: a common and important but underrecognized symptom. Supportive Care in Cancer 2006; 14: 693-698. [link]
Del Fabbro E (2011)
Del Fabbro E, Hui D, Dalai S et al. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med 2011; 14: 1004-1008.
Del Fabbro E (2010)
Del Fabbro E, Hui D, MD, Zohra Iet al. Associations among hypogonadism, C-reactive protein, symptom burden and survival in male cancer patients with cachexia: a preliminary report J Pain Symptom Manage 2010; 39;1016-1024.
Del Rio MI (2012)
Del Rio MI, Shand B, Bonati P et al. Hydration and nutrition at the end of life: a systematic review of emotional impact, perceptions and decision-making among patients, family and health care staff. Psycho-oncology 2012; 21: 913-
Desport JC (2000a)
Desport JC, Gory-Delabaere G, Blanc-Vincent MP et al. Standards, options and recommendations for the use of appetite stimulants in oncology (2000). British Journal of Cancer 2003; 89 (Supplement 1), S98-S100.
Desport JC (2000b)
Desport JC, Preux PM, Truong CT et al. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Dis 2000; 1: 91-96. [link]
Dewey A (2007)
Dewey A, Baughan C, Dean T et al. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database of Systematic reviews 2007; 1: CD004597.
Dobrila-Dintinjana RD (2012)
Dobrila-Dintinjana RD, Trivanovic D, Zelic M. Nutritional support in patients with colorectal cancer during chemotherapy: dose it work?. Hepatogastroenterology 2012; 60: Oct 29;60(123). doi: 10.5754/hge12710.
Donthireddy KR (2007)
Donthireddy KR, Ailawadhi S, Nasser E et al. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 2007; 5: 355-363.
Duerksen DR (2004)
Duerksen DR, Ting E, Thompson P et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 2004; 20: 760-763.
Dupuis L (2011)
Dupuis L, Pradat PF, Albert C Ludolph AC et al. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011; 10: 75-82.
Efthimiou J (1992)
Efthimiou J, Mournsey PJ, Benson DN et al. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive pulmonary disease. Thorax 1992; 47: 451-456.
Elia M (2006)
Elia M, Bokhorst-van der Schueren MA, Garvey J et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. International Journal of Oncology 2006; 28: 5-23.
Ellegard LH (2008)
Ellegard LH, Bosaeus IG. Biochemical indices to assess nutritional support for malignant disease. Clinica Chimica Acta 390 (2008) 23–27.
Evans WJ (2008)
Evans WJ, Morley JE, Argilés J et al. Cachexia: a new definition. Clinical Nutrition 2008; 27: 793-799.
Evans WK (1987)
Evans WK, Nixon DW, Daly JM et al. A randomised study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small cell lung cancer. J Clin Oncol 1987; 5: 113-124. [link]
Fearon KC (2006)
Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. American Journal of Clinical Nutrition 2006; 83: 1345-1350.
Fearon KC (2011a)
Fearon KC. The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes. Clin Nutr 2012; 31: 577-582.
Fearon K (2011b)
Fearon K, Strasser F, Anker SD et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
Fearon KC (2012)
Fearon KC, Glass DJ, Gluttridge DC. Cancer cachexia: mediators, signaling and metabolic pathways. Cell Metabol 2012; 16: 153-166.
Ferreira IM (2012)
Ferreira IM, Brookes D, White J et al. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; CD000998.
Finocchiaro E (2007)
Finocchiaro E, Rahimi F, Agnello E et al. Home parenteral nutrition in advanced cancer patients: a four-year multicenter prospective observational study. Nutr Ther Metab 2007; 25: 31-39.
Forbes RB (2004)
Forbes RB, Collins S, Swingler RJ et al. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neuron disease – a record linkage study from the Scottish Motor Neuron Disease Register. J Neurol 2004; 251: 813-817. [link]
Frankfort JD (1991)
Frankfort JD, Fischer CE, Stansbury DW et al. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 1991; 100: 792-795.#Frankfort JD, Fischer CE, Stansbury DW et al. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 1991; 100: 792-795.
Freeman LM (2009)
Freeman LM. The pathophysiology of cancer cachexia. Curr Opin Support Palliat Care 2009; 3: 276-281.Fudim M, Wagman G, Altschui et al. Pathophysiology and treatment options for cardiac anorexia. Curr Heart Fail Rep 2011; 8:147-153.
Fudim M (2011)
Fudim M, Wagman G, Altschul R et al. Pathofysiology and treatment options for cardiac anorexia. Curr Heart Fail Rep 2011; 8: 147-153.
Genton L (2011)
Genton L, Viatte V, Janssens JP, et al. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr 2011; 30 : 553-9.
Good P (2008)
Good P, Cavenagh J, Mather M et al. Medically assisted nutrition for palliative care in adult patients. Cochrane Database of Systematic Reviews 2008; 4: CD006274.
Hoda D (2005)
Hoda D, Jatoi A, Burnes J et al. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer 2005; 103: 863-868.
Holden CM (1991)
Holden CM. Anorexia in the terminally ill cancer patient: the emotional impact on the patient and the family. Hospital Journal 1991; 7: 73-84.
Holden CM (1993)
Holden CM. Nutrition and hydration in the terminally ill cancer patient: the nurse’s role in helping patients and families cope. Hospice Journal 1993; 9: 15-35.
Holm T (2013)
Holm T, Maier A, Wicks P et al. Severe loss of appetite in amyotrophic lateral sclerosis patients: on-line self-assessment study. Int J Med Res 2013; 2: e8.
IKNL. Richtlijn ondervoeding, versie 1.0, 2012.
Illman J (2006)
Illman J, Corringham R, Robinson D Jr et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression? Journal of Supportive Oncology 2006; 3: 37-50. [link]
Ingenbeek Y (1985)
Ingenbeek Y, Carpentier Y. Prognostic inflammatory and nutritional index scoring critically ill patients. Internat J Vit Nutr 1985; 55: 91-101. [link]
Inui A (2002)
Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer Journal for Clinicians 2002; 52: 72-91. [link]
Itoh M (2013)
Itoh M, Tsuji T, Nemoto K et al. Undernutrition in patients with COPD and its treatment. Nutrients 2013; 5: 1316-1335. [link]
Jatoi A (2010)
Jatoi A, Loprinzi CL. Clinical features and pathogenesis of cancer cachexia. UpToDate, 2010.
Jensen GL (2010)
Jensen GL, Mirtallo J, Compher C et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. Journal of Parenteral and Enteral Nutrition 2010; 34: 156-159.
Kasarkis EJ (1999)
Kasarkis EJ, Scarlata D, Hill R et al. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sciences 1999; 169: 118-125.
Katzberg HD (2011)
Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motorneuron disease. Cochrane Database Syst Rev 2011; 1: CD004030.
King LA (1993)
King LA, Carson LF, Konstantinides N et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: What have we learned in a decade of experience? Gynec Oncol 1993; 51: 377-382.
Kotler DP (2000)
Kotler DP. Cachexia. Annals of Internal Medicine 2000; 133: 622-634.
Landelijke Werkgroep Diëtisten Oncologie (2013)
Landelijke Werkgroep Diëtisten Oncologie. Landelijke richtlijn algemene voedings- en dieetbehandeling, 2013. www.oncoline.nl/Voeding en Dieet/Algemeen
Langmore SE (2006)
Langmore SE, Kasarkis EJ, Manca ML et al. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2006; 1: CD004030.
Lasheen W (2010)
Lasheen W, Walsh D. The cancer anorexia-cachexia syndrome: myth or reality? Support Care Cancer 2010; 18: 265-272.
Lundholm K (2004)
Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 2004;100:1967-1977.
Madhok BM (2011)
Madhok BM, Yeluri S, Haigh K et al. Parenteral nutrition for patients with advanced ovarian malignancy. J Human Nutrit Diet 2011; 24: 187-191.
Mazzini L (1995)
Mazzini L, Corra T, Zaccala M et al. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242: 695-698.
McCallum R (1991)
McCallum R, Valenzuela G, Polepalle S et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 1991; 258: 136-142.
McCann RM (1994)
McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994; 272: 1263-1266.
McClement S (2005)
McClement S. Cancer anorexia-cachexia syndrome: psychological effect on the patient and family. Journal of wound, ostomy and continence nursing 2005; 2005; 32: 264-268.
McMillan DC (2009)
McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-226.
Meares CJ (1997)
Meares CJ. Primary caregiver perceptions of intake cessation in patients who are terminally ill. Oncology Nursing Forum 1997; 24: 1751-1757.
Meier DE (2001)
Meier DE, Ahronheim JC, Morris J, Baskin-Lyons S, Morrison RS. High short-term mortality in hospitalized patients with advanced dementia: Lack of benefit of tube feeding. Archives of Internal Medicine 2001;161(4):594–9.
Meijers JM (2010)
Meijers JM, Bokhorst-van der Schueren van MA, Schols JM et al. Defining malnutrition: mission or mission impossible? Nutr 2010; 26: 432-440.
Mercadante S (1995)
Mercadante S. Parenteral nutrition at home in advanced cancer patients. J Pain Symptom Manage 1995; 10: 476-480.
Miján-de-la-Torre A (2009)
Miján-de-la-Torre A. Recent insights on chronic heart failure, cachexia and nutrition. Curr Opin Clin Metab Care 2009; 12: 251-257.
Miller RG (2009)
Miller RG, Jackson CE, Kasarkis EJ et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of neurology. Neurology 2009; 73: 1218-1226.
Mirhosseini N (2005)
Mirhosseini N, Fainsinger RL, Baracos V. Parenteral nutrition in advanced cancer: indications and clinical practice guidelines. Journal of Palliative Medicine 2005; 8: 914-918.
Mitchell JD (2006)
Mitchell JD, O’Brien MR, Joshi M. Audit of outcomes in motor neuron disease patients treated with riluzole. Amyotroph Lateral Scler 2006; 7: 67-71.2006.
Mitsumoto H (2003)
Mitsumoto H, Davidson M, Moore D et al. Percutaneous endoscopic gastrostomy in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Dis 2003; 4: 177-185.
Morley JE (2006)
Morley JE, Thomas DR, Wilson MMG. Cachexia: pathofysiology and clinical relevance. Am J Clin Nutr 2006; 83: 735-743.
Murphy M (2008)
Murphy M, Quinn S, Young J et al. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008; 71: 1889-1895.
Muscaritoli M (2010)
Muscaritoli M, Anker SD, Argilés J et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010; 29: 154-159. [link]
Muscaritoli M (2012)
Muscaritoli M, Molfino A, Laviano A et al. Parenteral nutrition in advanced cancer patients. Clin Rev Oncol/Hematol 2012; 84: 26-36.
Nelson KA (2002)
Nelson KA, Walsh D. The cancer anorexia-cachexia syndrome: a survey of the prognostic inflammatory and nutritional Index ( PINI) in advanced disease. J Pain Symptom Manage 2002; 24; 424-428.
Nelson KA (1993)
Nelson KA, Walsh TD. Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). Journal of Palliative Care 1993; 9: 14-18.
Nourissat A (2008)
Nourissat A, Vasson MP, Merrouche Y, Bouteloup C, Goutte M, Mille D, et al. Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer 2008; 44: 1238-1242.
Okoshi MP (2013)
Okoshi MP, Romeiro FG, Paiva SA, Okoshi K. Heart failure-induced cachexia. Arq Bras Cardiol 2013 May;100(5):476-82.
Orreval Y (2009)
Orreval Y, Tishelman C, Permert J, Cederholm T. The use of artificial nutrition among cancer patients enrolled in palliative home care services. Palliat Med 2009; 23: 556-564.
Orreval Y (2013)
Orreval Y, Tishelman C, Permert J, Lundstrom S. A national observational study of the prevalence and use of enteral feeding, parenteral nutrition and intravenous glucose in cancer patients enrolled in specialized palliative care, Nutrients 2013; 5: 267-282.
Orreval Y (2005)
Orreval Y, Tishelman C, Permert J. Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clinical Nutrition 2005; 24: 961–70.
Pasanisi F (2001)
Pasanisi F, Orban A, Scalfi L et al. Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 2001; 17: 581-584.
Philip J (1997)
Philip J, Depczynski B. The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy. J Pain Symptom Manage 1997; 13: 104-111.
Pironi L (1997)
Pironi L, Ruggeri E, Tanneberger S, Giordani S, Pannuti F, Miglioli M. Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine 1997; 90: 597–603.
Poole K (2002)
Poole K, Froggatt K. Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Palliat Med. 2002 Nov;16(6):499-506.
Prevost V (2012)
Prevost V, Grach MC. Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care 2012; 21: 581-590.
Radbruch L (2010)
Radbruch L, Elsner F, Trottenberg P et al. Clinical practice guidelines on cancer cachexia in advanced cancer patients. Aachen, Department of palliative medicine/European palliative care research collaborative, 2010.
Sandek A (2009)
Sandek A, Doehner W, Anker SD et al. Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care 2009; 12: 384-391.
Santarpia L (2006)
Santarpia L, Alfonsi L, Pasanisi F et al. Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition 2006; 22: 355-360.
Sarhill N (2003)
Sarhill N, Mahmoud FA, Christie R, Tahir A. Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hosp Palliat Care. 2003; 20:465-473.
Schols AM (1995)
Schols AM, Soeters PB, Mostert R et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 1268-1274.
Schols AMWJK (1998)
Schols AMWJK, Slangen J, Volovics L. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1998; 157: 1791-1797.
Schols AM (2009)
Schols AM, Gosker HR. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Curr Opin Support Palliat Care. 2009 Dec;3(4):282-
Shivshankar K (1983)
Shivshankar K, Bennett R, Haynie T. Tumor-associated gastroparesis: correction with metoclopramide. American Journal of Surgery 1983; 145: 221-225.
Shragge JE (2006)
Shragge JE, Wismer WV, Olson KL et al. The management of anorexia by patients with advanced cancer: a critical review of the literature. Palliative Medicine 2006; 20: 623-629.
Slinde F (2002)
Slinde F, Gronberg AM, Engstrom CR et al. Individual dietary intervention in patients with COPD during multidisciplinary rehabilitation. Respir Med 2002; 96: 330-336.
Soeters PB (2008)
Soeters PB, Reijven PL, Bokhorst-van der Schueren van MA et al. A rational approach to nutritional assessment. Clinical Nutrition 2008; 27: 706-716.
Soeters PB (2009)
Soeters PB, Schols AMWJ. Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 2009; 12:487–494
Sorenson EJ (2007)
Sorenson EJ, Crum B, Stevens JC. Incidence of aspiration pneumonia in ALS in Olmsted County, MN. Amyotroph Lateral Scler 2007; 8: 87-89.
Steiner MC (2003)
Steiner MC, Barton RL, Singh SJ et al. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2003; 58: 745-751.
Strasser F (2007)
Strasser F. Appraisal of current and experimental approaches to the treatment of cachexia. Curr Opin Support Palliat Care. 2007 Dec;1(4):312-6.
Strong MJ (1999)
Strong MJ, Rowe A, Rankin RN. Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. J Neurol Sciences 1999; 169: 128-132.
Suchner U (1990)
Suchner U, Rothkopf MM, Stanislaus G et al. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990; 150: 1225-1230.
Suh SY (2013)
Suh SY, Choi YS, Yeom CH et al Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer.Support Care Cancer. 2013 Jul 5.
Tan BHL (2008)
Tan BHL, Fearon KCH. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutrit Met Care 2008; 11: 400-407.
Tandon SP (1984)
Tandon SP, Gupta SC, Sinha SN et al. Nutritional support as an adjunct therapy of advanced cancer patients. Indian J Med Res 1984; 80: 180-188
Tisdale MJ et al (2009)
Tisdale MJ et al. Mechanisms of cancer cachexia. Physiol Rev 2009; 89; 381-410.
Tisdale MJ (2010)
Tisdale MJ. Cancer cachexia. Cur Opin Gastroenterol 2010; 26:146-151.
Topkan E (2007)
Topkan E Ali Aydin Yavuz AA, Ozgur Ozyilkan O. Cancer cachexia: pathophysiologic aspects and treatment options. Asian Pacific J Cancer Prev 2007; 8: 445-451.
Van Cutsem E (2005)
Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9: S51-S63.
Vermeeren MAP (2001)
Vermeeren MAP, Wouters EFM, Nelissen LH et al. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2001; 73: 295-301.
Vogel J (2012)
Vogel J, Beijer S, Doornink N, Wipkink A (red). Handboek Voeding bij Kanker. Utrecht: de Tijdstroom, 2012.
Von Haehling S (2009)
Von Haehling S, Mitja Lainscak M, Jochen Springer J et al. Cardiac cachexia: a systematic overview. Pharmacol Therapeut 2009; 121: 227-252.
Wallengren O (2013)
Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 2013; 21: 1569-1577
Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 2003; 11: 60-62
Weiss SM (1982)
Weiss SM, Worthington PH, Prioleau M, Rosato FE. Home total parenteral nutrition in cancer patients. Cancer 1982; 50: 1210-1213.
Whittaker JS (1990)
Whittaker JS, Ryan CF, Buckley PA, Road JD. The effect of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis 1990; 142: 283-288.
Whitworth MK (2004)
Whitworth MK, Whitfield A, Holm S et al. Doctor, does this mean I'm going to starve to death? J Clin Oncol 2004; 22: 199-201.
Yavuszen T (2009)
Yavuszen T, Walsh D, Davis MP et al. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer cachexia. Support Care Cancer 2009; 17: 1531-1541.